Japan's DSP to buy US cancer start-up for $2.6 bn
Japanese drugs giant Dainippon Sumitomo Pharma will buy US biotechnology cancer specialist Boston Biomedical for a price that could hit $2.6 billion, the companies announced Thursday.
Mar 1, 2012
0
0